U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula F.K.2H2O
Molecular Weight 94.1273
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of POTASSIUM FLUORIDE DIHYDRATE

SMILES

O.O.[F-].[K+]

InChI

InChIKey=MZFXHSQFQLKKFD-UHFFFAOYSA-M
InChI=1S/FH.K.2H2O/h1H;;2*1H2/q;+1;;/p-1

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula F
Molecular Weight 18.9984032
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula K
Molecular Weight 39.0983
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Potassium is needed to maintain good health. When potassium level falls below 3.5 mmol/L, Hypokalemia is diagnosed. In case of extremely low level of potassium (lower than 2.5 mmol/L) the following symptoms are appeared: malaise and fatigue. This low level of potassium can lead to severe muscle weakness and paralysis; respiratory failure; intermittent muscle spasms. It is known, foods that are good sources of potassium and low in sodium may reduce the risk of high blood pressure and stroke. Potassium supplementation is also recommended as an adjuvant antihypertensive agent for patients with essential hypertension.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
2003-02-14
Delay of natural bone loss by higher intakes of specific minerals and vitamins.
2001-05
Inhibition of HIV-1 infection by zinc group metal compounds.
1999-09
Diet, genetics and hypertension.
1997-08
Mineral and water nutrition.
1991-07
Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks.
1991-05-15
Patents

Sample Use Guides

Potassium is administered in various dosage forms (gluconate, citrate, chloride, bicarbonate). Exact dose should be determined by a doctor. Most people will not take more than 100 mEq a day.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:48:46 GMT 2025
Edited
by admin
on Mon Mar 31 18:48:46 GMT 2025
Record UNII
95R1D12HEH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
POTASSIUM FLUORIDE DIHYDRATE [MI]
Preferred Name English
POTASSIUM FLUORIDE DIHYDRATE
MI  
Systematic Name English
Code System Code Type Description
FDA UNII
95R1D12HEH
Created by admin on Mon Mar 31 18:48:47 GMT 2025 , Edited by admin on Mon Mar 31 18:48:47 GMT 2025
PRIMARY
CAS
13455-21-5
Created by admin on Mon Mar 31 18:48:47 GMT 2025 , Edited by admin on Mon Mar 31 18:48:47 GMT 2025
PRIMARY
PUBCHEM
23708904
Created by admin on Mon Mar 31 18:48:47 GMT 2025 , Edited by admin on Mon Mar 31 18:48:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID90928668
Created by admin on Mon Mar 31 18:48:47 GMT 2025 , Edited by admin on Mon Mar 31 18:48:47 GMT 2025
PRIMARY
MERCK INDEX
m9023
Created by admin on Mon Mar 31 18:48:47 GMT 2025 , Edited by admin on Mon Mar 31 18:48:47 GMT 2025
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE